George Lyon is an Infectious Disease physician affiliated with Emory University. OpenAlex indexes 43 publications with 878 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Infectivity of Norovirus in Groundwater-Human Challenge Study
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
80.1%Other antibacterials13.8%Methenamine Hippurate100%Part D≥15 patientsTetracycline-class Drug13.6%Doxycycline Hyclate53%Doxycycline Monohydrate24%Minocycline Hcl22%Part D<11 patients+ 9 more classes in this area
Nervous system
8%Benzodiazepine4.9%Alprazolam100%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator3%Zolpidem Tartrate100%Part D<11 patientsMetabolism & gastrointestinal
4%Proton pump inhibitor4%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial2022
- Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers
Transplant Infectious Disease
2021 - Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report
Open Forum Infectious Diseases
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
Laurence Sperling, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”